Skip to main content
Clinical Trials/NCT01811342
NCT01811342
Completed
Not Applicable

Evaluation of the Masimo Continuous Hemoglobin Monitor With Polar Plot Methodology

University of California, Davis1 site in 1 country70 target enrollmentStarted: November 2012Last updated:
ConditionsAnemia

Overview

Phase
Not Applicable
Status
Completed
Enrollment
70
Locations
1
Primary Endpoint
Evaluation of the Masimo Continuous Hemoglobin Monitor with Polar Plot Methodology

Overview

Brief Summary

Evaluate potential sources of error that affect the accuracy of continuous hemoglobin monitoring.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients undergoing elective surgery.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Evaluation of the Masimo Continuous Hemoglobin Monitor with Polar Plot Methodology

Time Frame: One year

Determine the influence of initial calibration and intraoperative oxygenation variables on the correlation between SpHgb and clinical values

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials